Cabin fever {#cesec10}
===========

The global incidence of dengue fever is on the rise, especially in southeast Asia and the Americas. New research suggests much of this spread is caused by aeroplane travel. Researchers did a phylogenetic analysis of 2202 viral sequences from [dengue virus](http://dx.doi.org/10.1371/journal.pntd.0005694){#interrefs10} samples collected in 20 countries between 1956 and 2015. They also assessed air travel, maritime mobility, migration, and socioeconomic factors for associated trends. Spread of dengue serotypes 1, 2, and 3 was associated with air travel more than any other factor. The findings suggest that Thailand and India have acted as hubs for seeding new epidemics.

Ready or not {#cesec20}
============

Researchers have developed an assay that could help find and clear HIV hiding dormant in T cells. They showed that [vorinostat](http://dx.doi.org/10.1016/j.ebiom.2017.07.019){#interrefs20}, a drug marketed for haematological cancers, can reverse latency and cause infected cells to express viral antigens, leaving them susceptible to clearance by immune effector mechanisms. Further work is needed to find the best combination of latency-reversing agents, including vorinostat, and clearance strategies. The team says that their assay can be used to assess these combinations in future studies.

It\'s (not) in his kiss {#cesec30}
=======================

Saliva, it seems, is not a viable route for [Zika virus transmission](http://dx.doi.org/10.1038/s41467-017-00246-8){#interrefs30}, dampening concerns of potential transmission via kissing. Researchers swabbed the tonsils of five uninfected rhesus macaques with saliva from infected monkeys---none got infected. They then swabbed the tonsils of three other uninfected monkeys with high-concentration Zika virus in solution (80 000 times the concentration in saliva), all of which became infected. In experiments in monkey cells, they showed that the presence of saliva reduces the virus\' ability to infect cells, presumably thanks to [antimicrobial](http://dx.doi.org/10.1056/NEJMoa1615822){#interrefs40} activity and an already low concentration of infectious particles in saliva.

Infections and HIV {#cesec40}
==================

10% of people with advanced HIV in sub-Saharan Africa die from another infection shortly after starting antiretroviral treatment. In a trial in 1805 patients (1733 adults and 72 children or adolescents) in Kenya, Malawi, Uganda, and Zimbabwe, researchers tested whether or not enhanced prophylaxis including continuous trimethoprim--sulfamethoxazole and at least 12 weeks of isoniazid--pyridoxine, 12 weeks of fluconazole, 5 days of azithromycin, and a dose of albendazole improved 24 week mortality versus trimethoprim--sulfamethoxazole alone. It did: 80 deaths (9%) with advanced prophylaxis versus 108 deaths (12%) with standard prophylaxis (hazard ratio 0·73, 95% CI 0·55--0·98; p=0·03).

Getting to know MERS {#cesec50}
====================

A better understanding of the [immunological response to infection](http://dx.doi.org/10.1126/sciimmunol.aan5393){#interrefs50} with Middle East Respiratory Syndrome (MERS) coronavirus is needed to guide vaccine development. In a study of blood samples from 21 Saudi Arabian MERS survivors, researchers identified CD4 and CD8 T-cell responses specific to the virus. They also identified neutralising antibodies that could be vaccine targets. These signature immune responses were present in patients with mild or asymptomatic infection, suggesting that analysis of T-cell responses could more accurately estimate viral prevalence than can visible symptoms. Further confirmatory studies are needed in a larger population and in people who work with dromedary camels, a host of the virus.

Going for gold {#cesec60}
==============

Molecular techniques for [predicting drug resistance in tuberculosis](http://dx.doi.org/10.1093/cid/cix556){#interrefs60} sputum samples are quicker than are traditional culture tests (hours *vs* weeks), but anxiety over how well they predict long-term outcomes has precluded their use as the gold standard test. Researchers assessed cough secretion samples from 171 patients with drug-resistant tuberculosis: 44 had mutations for resistance to one of several fluoroquinolones, which are used to treat drug-resistant strains. Patients who had mutations that conferred high-level resistance were three times more likely to respond poorly to treatment than were those with no resistance-causing mechanisms. Molecular sequencing outperformed standard testing in predicting resistance to ciprofloxacin and accurately predicted resistance to another two fluoroquinolones: levofloxacin and moxifloxacin.

The best laid plans... {#cesec70}
======================

Use of rapid diagnostic tests for malaria, meant to reduce unnecessary prescription of artemisinin combination therapies (ACTs) that could lead to resistance, might be leading to an unintended increase in prescription of antibiotics. Researchers reviewed drug prescriptions written between 2007 and 2013 for more than 562 000 patient visits in sub-Saharan Africa and Afghanistan. In most areas, 40--80% of patients who tested negative for malaria were given antibiotics. Irrespective of test outcome, 75% of patients received either antibiotics or an ACT, leaving the researchers to posit that doctors or patients might feel uncomfortable with what might be the best approach for [treatment of fever once malaria has been ruled out](http://dx.doi.org/10.4269/ajtmh.16-0955){#interrefs70}: antipyretics and plenty of water.
